======= GUCA2B =======
== Gene Information ==
* **Official Symbol**: GUCA2B
* **Official Name**: guanylate cyclase activator 2B
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2981|2981]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q16661|Q16661]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=GUCA2B&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GUCA2B|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/601271|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Endogenous activator of intestinal guanylate cyclase. It stimulates this enzyme through the same receptor binding region as the heat-stable enterotoxins. May be a potent physiological regulator of intestinal fluid and electrolyte transport. May be an autocrine/paracrine regulator of intestinal salt and water transport.
|Guanylin|
|guanylate cyclase activator activity|
|calcium sensitive guanylate cyclase activator activity|
|positive regulation of guanylate cyclase activity|
|regulation of guanylate cyclase activity|
|positive regulation of cyclase activity|
|positive regulation of purine nucleotide biosynthetic process|
|positive regulation of nucleotide biosynthetic process|
|positive regulation of lyase activity|
|cGMP-mediated signaling|
|regulation of purine nucleotide biosynthetic process|
|regulation of nucleotide biosynthetic process|
|excretion|
|regulation of cyclase activity|
|positive regulation of purine nucleotide metabolic process|
|positive regulation of nucleotide metabolic process|
|negative regulation of blood pressure|
|regulation of lyase activity|
|photoreceptor outer segment|
|body fluid secretion|
|digestion|
|regulation of purine nucleotide metabolic process|
|regulation of nucleotide metabolic process|
|positive regulation of small molecule metabolic process|
|cyclic-nucleotide-mediated signaling|
|regulation of blood pressure|
|second-messenger-mediated signaling|
|blood circulation|
|circulatory system process|
|regulation of small molecule metabolic process|
|regulation of body fluid levels|
|secretion|
|positive regulation of phosphate metabolic process|
|positive regulation of phosphorus metabolic process|
|positive regulation of catalytic activity|
|intracellular signal transduction|
|positive regulation of molecular function|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|positive regulation of nucleobase-containing compound metabolic process|
|extracellular region|
|system process|
|positive regulation of cellular biosynthetic process|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|-2.29|
|[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|-1.98|
|[[:results:exp100|NFN1 1μM R03 exp100]]|-1.82|
|[[:results:exp147|Resveratrol 16μM R03 exp147]]|-1.77|
|[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-1.75|
|[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|-1.71|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 8032
* **Expression level (log2 read counts)**: -1.85
{{:chemogenomics:nalm6 dist.png?nolink |}}